pc:owkin

OWKIN

831 Broadway Unit 3R New York, NY 10003, US

https://www.owkin.com/

Research Platforms

Owkin is a healthcare AI company that develops privacy-preserving machine learning models and a federated learning platform to enable collaborative biomedical research across hospitals, biopharma, and research institutions. The company applies multi-modal data analysis (e.g., genomics, pathology, imaging, and clinical data) to accelerate biomarker discovery, improve clinical trial design, and support drug discovery and precision medicine efforts.

Leadership & Board

Current Number of Employees402

Current LinkedIn Followers64,123

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$50M

Total Amount Raised$50M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$50M

Latest Funding Amount$50M

Latest Funding RoundSeries B

Latest Funding RoundSeries B

Post-Money Valuation―

Post-Money Valuation―

Company Momentum Positive

Articles Published on TipRanks10

Articles Published on TipRanks

10

LinkedIn Trend+0.31% followers

LinkedIn Trend

+0.31% followers

Workforce Trend0.7% employees

Workforce Trend

0.7% employees

OWKIN LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.

Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Funding Round

Jul 08, 2022

Series B

$50.00M

―

Investors

Bristol Myers Squibb

Series B

Bristol-Myers Squibb

Series B

Related News and Analysis

OWKIN – Weekly Recap

OWKIN – Weekly Recap

OWKIN featured prominently this week as it sharpened its pitch around K Pro, its “AI scientist” platform aimed...

2d ago

OWKIN Positions AI Platform to Capitalize on FDA’s Move Toward AI-Enabled Clinical Trials

OWKIN Positions AI Platform to Capitalize on FDA’s Move Toward AI-Enabled Clinical Trials

According to a recent LinkedIn post from OWKIN, the U.S. FDA is beginning to incorporate AI into clinical...

3d ago

OWKIN Highlights AI Platform Aimed at Accelerating Clinical Trial Timelines

OWKIN Highlights AI Platform Aimed at Accelerating Clinical Trial Timelines

According to a recent LinkedIn post from OWKIN, U.S. regulators are beginning to integrate artificial intelligence into clinical...

3d ago

OWKIN Highlights New Benchmark for Subgroup Analysis in Oncology Trials

OWKIN Highlights New Benchmark for Subgroup Analysis in Oncology Trials

According to a recent LinkedIn post from OWKIN, the company is highlighting a new peer-reviewed publication in BMC...

4d ago

OWKIN Highlights New Subgroup Analysis Benchmark for Oncology Trial Optimization

OWKIN Highlights New Subgroup Analysis Benchmark for Oncology Trial Optimization

A LinkedIn post from OWKIN highlights a new peer‑reviewed publication in BMC Medical Research Methodology on subgroup analysis...

4d ago

Owkin Highlights Open-Science Strategy and Ties to Hugging Face Ecosystem

Owkin Highlights Open-Science Strategy and Ties to Hugging Face Ecosystem

According to a recent LinkedIn post from OWKIN, the company is emphasizing the importance of open science and...

5d ago

OWKIN Highlights AI-Centered Oncology Trends and Positions K Pro for Implementation Gap

OWKIN Highlights AI-Centered Oncology Trends and Positions K Pro for Implementation Gap

According to a recent LinkedIn post from OWKIN, the company is emphasizing how artificial intelligence is becoming central...

5d ago

Owkin Highlights Open-Science Contributions and AI Pathology Integration

Owkin Highlights Open-Science Contributions and AI Pathology Integration

According to a recent LinkedIn post from OWKIN, the company is highlighting the launch of Hugging Face’s new...

5d ago

OWKIN Positions K Pro Platform at Center of Emerging AI Oncology Workflows

OWKIN Positions K Pro Platform at Center of Emerging AI Oncology Workflows

According to a recent LinkedIn post from OWKIN, the company is emphasizing the growing centrality of artificial intelligence...

5d ago

Owkin Showcases K Pro AI Scientist Platform and Proprietary Biomedical Models

Owkin Showcases K Pro AI Scientist Platform and Proprietary Biomedical Models

According to a recent LinkedIn post from OWKIN, the company is emphasizing the scientific underpinnings of its K...

6d ago